Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement.

Kotloff RM, Blosser S, Fulda GJ, Malinoski D, Ahya VN, Angel L, Byrnes MC, DeVita MA, Grissom TE, Halpern SD, Nakagawa TA, Stock PG, Sudan DL, Wood KE, Anillo SJ, Bleck TP, Eidbo EE, Fowler RA, Glazier AK, Gries C, Hasz R, Herr D, Khan A, Landsberg D, Lebovitz DJ, Levine DJ, Mathur M, Naik P, Niemann CU, Nunley DR, O'Connor KJ, Pelletier SJ, Rahman O, Ranjan D, Salim A, Sawyer RG, Shafer T, Sonneti D, Spiro P, Valapour M, Vikraman-Sushama D, Whelan TP; Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Donor Management Task Force.

Crit Care Med. 2015 Jun;43(6):1291-325. doi: 10.1097/CCM.0000000000000958.

PMID:
25978154
2.

Mechanical ventilation after lung transplantation. It's time for a trial.

Diamond JM, Ahya VN.

Ann Am Thorac Soc. 2014 May;11(4):598-9. doi: 10.1513/AnnalsATS.201403-104ED. No abstract available.

PMID:
24828803
3.

Decreased incidence of cytomegalovirus infection with sirolimus in a post hoc randomized, multicenter study in lung transplantation.

Ghassemieh B, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Charbeneau J, Garrity ER, Bhorade SM.

J Heart Lung Transplant. 2013 Jul;32(7):701-6. doi: 10.1016/j.healun.2013.04.010. Epub 2013 May 7.

PMID:
23664526
4.

Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.

Karuturi M, Shah N, Frank D, Fasan O, Reshef R, Ahya VN, Bromberg M, Faust T, Goral S, Schuster SJ, Stadtmauer EA, Tsai DE.

Transpl Int. 2013 Jun;26(6):616-22. doi: 10.1111/tri.12091. Epub 2013 Mar 28.

5.

Interobserver variability in grading transbronchial lung biopsy specimens after lung transplantation.

Bhorade SM, Husain AN, Liao C, Li LC, Ahya VN, Baz MA, Valentine VG, Love RB, Seethamraju H, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Garrity ER, Arcasoy SM.

Chest. 2013 Jun;143(6):1717-24. doi: 10.1378/chest.12-2107.

PMID:
23370547
6.

University of Pennsylvania Lung Transplantation: update 2012.

Lee JC, Blumenthal NP, Kotloff RM, Cantu E, Ahya VN; University of Pennsylvania Lung Transplant Program.

Clin Transpl. 2012:145-54.

7.

Post-transplant lymphoproliferative disorder after lung transplantation: a review of 35 cases.

Kremer BE, Reshef R, Misleh JG, Christie JD, Ahya VN, Blumenthal NP, Kotloff RM, Hadjiliadis D, Stadtmauer EA, Schuster SJ, Tsai DE.

J Heart Lung Transplant. 2012 Mar;31(3):296-304. doi: 10.1016/j.healun.2011.10.013. Epub 2011 Nov 23.

PMID:
22112992
8.

Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis.

Diamond JM, Lederer DJ, Kawut SM, Lee J, Ahya VN, Bellamy S, Palmer SM, Lama VN, Bhorade S, Crespo M, Demissie E, Sonett J, Wille K, Orens J, Shah PD, Weinacker A, Weill D, Kohl BA, Deutschman CC, Arcasoy S, Shah AS, Belperio JA, Wilkes D, Reynolds JM, Ware LB, Christie JD; Lung Transplant Outcomes Group.

Am J Transplant. 2011 Nov;11(11):2517-22. doi: 10.1111/j.1600-6143.2011.03702.x. Epub 2011 Aug 22.

9.

Conventional and novel approaches to immunosuppression.

Floreth T, Bhorade SM, Ahya VN.

Clin Chest Med. 2011 Jun;32(2):265-77. doi: 10.1016/j.ccm.2011.02.012. Review.

PMID:
21511089
10.

Effect of single vs bilateral lung transplantation on plasma surfactant protein D levels in idiopathic pulmonary fibrosis.

Sims MW, Beers MF, Ahya VN, Kawut SM, Sims KD, Lederer DJ, Palmer SM, Wille K, Lama VN, Shah PD, Orens JB, Bhorade S, Crespo M, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB; Lung Transplant Outcomes Group.

Chest. 2011 Aug;140(2):489-96. doi: 10.1378/chest.10-2065. Epub 2011 Feb 24.

11.

Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.

Diamond JM, Kawut SM, Lederer DJ, Ahya VN, Kohl B, Sonett J, Palmer SM, Crespo M, Wille K, Lama VN, Shah PD, Orens J, Bhorade S, Weinacker A, Demissie E, Bellamy S, Christie JD, Ware LB; Lung Transplant Outcomes Group.

Am J Transplant. 2011 Mar;11(3):561-7. doi: 10.1111/j.1600-6143.2010.03431.x. Epub 2011 Feb 7.

12.

Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.

Ahya VN, McShane PJ, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Garrity E, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Bhorade S.

J Heart Lung Transplant. 2011 Feb;30(2):175-81. doi: 10.1016/j.healun.2010.08.010. Epub 2010 Oct 13.

PMID:
20947384
13.

Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fibrosis.

Fang A, Studer S, Kawut SM, Ahya VN, Lee J, Wille K, Lama V, Ware L, Orens J, Weinacker A, Palmer SM, Crespo M, Lederer DJ, Deutschman CS, Kohl BA, Bellamy S, Demissie E, Christie JD; Lung Transplant Outcomes Group.

Chest. 2011 Apr;139(4):782-7. doi: 10.1378/chest.09-2806. Epub 2010 Sep 23.

14.

Comparison of sirolimus with azathioprine in a tacrolimus-based immunosuppressive regimen in lung transplantation.

Bhorade S, Ahya VN, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Alex CG, Bag R, Deoliveira NC, Husain A, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Garrity E.

Am J Respir Crit Care Med. 2011 Feb 1;183(3):379-87. doi: 10.1164/rccm.201005-0775OC. Epub 2010 Sep 10.

PMID:
20833822
15.

Lung transplantation in autoimmune diseases.

Lee JC, Ahya VN.

Clin Chest Med. 2010 Sep;31(3):589-603. doi: 10.1016/j.ccm.2010.05.003. Review.

PMID:
20692549
16.

Donor transmission of malignant melanoma in a lung transplant recipient 32 years after curative resection.

Bajaj NS, Watt C, Hadjiliadis D, Gillespie C, Haas AR, Pochettino A, Mendez J, Sterman DH, Schuchter LM, Christie JD, Lee JC, Ahya VN.

Transpl Int. 2010 Jul;23(7):e26-31. doi: 10.1111/j.1432-2277.2010.01090.x. Epub 2010 Apr 28.

17.

Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction.

Christie JD, Shah CV, Kawut SM, Mangalmurti N, Lederer DJ, Sonett JR, Ahya VN, Palmer SM, Wille K, Lama V, Shah PD, Shah A, Weinacker A, Deutschman CS, Kohl BA, Demissie E, Bellamy S, Ware LB; Lung Transplant Outcomes Group.

Am J Respir Crit Care Med. 2009 Nov 15;180(10):1010-5. doi: 10.1164/rccm.200901-0118OC. Epub 2009 Aug 6.

18.

Central airways obstruction due to Aspergillus fumigatus after lung transplantation.

Cerceo E, Kotloff RM, Hadjiliadis D, Ahya VN, Pochettino A, Gillespie C, Christie JD.

J Heart Lung Transplant. 2009 May;28(5):515-9. doi: 10.1016/j.healun.2009.01.024. Epub 2009 Apr 5.

19.

Risk factors for early primary graft dysfunction after lung transplantation: a registry study.

Kuntz CL, Hadjiliadis D, Ahya VN, Kotloff RM, Pochettino A, Lewis J, Christie JD.

Clin Transplant. 2009 Nov-Dec;23(6):819-30. doi: 10.1111/j.1399-0012.2008.00951.x. Epub 2009 Feb 20.

PMID:
19239481
20.

Lung transplant outcomes in white and African American recipients: special focus on acute and chronic rejection.

Lingaraju R, Pochettino A, Blumenthal NP, Mendez J, Lee J, Christie JD, Kotloff RM, Ahya VN, Hadjiliadis D.

J Heart Lung Transplant. 2009 Jan;28(1):8-13. doi: 10.1016/j.healun.2008.10.014. Epub 2008 Dec 11.

PMID:
19134524
Items per page

Supplemental Content

Loading ...
Write to the Help Desk